Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer
Carlos Perez‐Stable(University of Miami), Andrew V. Schally(University of Miami)
Cited by 0
Related Papers
Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
|Proceedings of the National Academy of Sciences|1997|138
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis
|Proceedings of the National Academy of Sciences|2002|124
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
|PeerJ|2013|56
Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer
|Proceedings of the National Academy of Sciences|2009|36